Menu

2021 AONN+ Annual Virtual Conference Agenda*

All sessions CE unless otherwise noted.

Wednesday, November 17

11:00 am - 1:00 pm ET
Preconference Workshop 1A | Nutrition
11:00 am - 1:00 pm ET
Preconference Workshop 2A | All the Things You Wish You Knew/ABCs to Start a Navigation Program
11:00 am - 1:00 pm ET
Preconference Workshop 3A | Palliative Care: What Navigators Need to Know
11:00 am - 1:00 pm ET
Preconference Workshop 4A | Survivorship
1:00 pm - 2:00 pm ET
Industry Sponsored Session | Considerations for the Treatment of Patients with Lung Cancer: Resectable NSCLC and Unresectable Stage III NSCLC Presented by AstraZeneca (non-CE)
2:00 pm - 4:00 pm ET
Preconference Workshop 1B | Nutrition
2:00 pm - 4:00 pm ET
Preconference Workshop 2B | All the Things You Wish You Knew/ABCs to Start a Navigation Program
2:00 pm - 4:00 pm ET
Preconference Workshop 3B | Palliative Care: What Navigators Need to Know
2:00 pm - 4:00 pm ET
Preconference Workshop 4B | Survivorship
5:30 pm - 7:00 pm ET
Industry Town Hall Reception (non-CE)

Thursday, November 18

8:00 am - 9:00 am ET
Welcome, Opening Remarks, and Awards (non-CE)
9:15 am - 10:15 am ET
General Session 1 | Genetics & Genomics
10:30 am - 11:30 am ET
Industry Sponsored Session | What You Can Do Today for Your KRAS G12C–Mutated NSCLC Patients Presented by Amgen (non-CE)
10:30 am - 11:30 am ET
Industry Sponsored Session | Consider TRODELVY® (sacituzumab govitecan-hziy) for Your Patients: An FDA-Approved Trop-2 Directed Antibody–Drug Conjugate Presented by Gilead (non-CE)
11:45 am - 12:45 pm ET
General Session 2 | Technology in Cancer Care
1:00 pm - 2:00 pm ET
Industry Sponsored Session | A Combination Treatment for Patients with Advanced Renal-Cell Carcinoma Presented by Exelixis (non-CE)
2:15 pm - 3:15 pm ET
General Session 3 | Policy and Advocacy: Screening
3:30 pm - 4:30 pm ET
General Session 4 | Precision Medicine
4:45 pm - 5:45 pm ET
Industry Sponsored Session | A Treatment Option for Patients with Certain Types of Advanced Endometrial Carcinoma Presented by Eisai (non-CE)
6:00 pm - 7:00 pm ET
AONN+ Cancer Advocacy & Patient Education Programs

Friday, November 19

8:00 am - 9:00 am ET
Industry Sponsored Session | Urgent Treatment of Early-Onset Severe Toxicity of 5-FU or Capecitabine Presented by Wellstat Therapeutics (non-CE)
9:15 am - 10:15 am ET
Keynote Session | Tamika Felder: Ending Cervical Cancer Is Within Our Reach
10:30 am - 11:30 am ET
Industry Sponsored Session | Educate Your Patients on IMBRUVICA® (ibrutinib) Treatment Presented by Pharmacyclics LLC, an AbbVie Company, and Janssen Biotech, Inc. (non-CE)
10:30 am - 11:30 am ET
Industry Sponsored Session | Evolving CLL Treatment Paradigms Exploring Chemo-Free Regimens with a Fixed Treatment Duration Presented by Genentech (non-CE)
11:00 am - 12:30 pm ET
Exhibit Hall Open (non-CE)
12:30 pm - 1:30 pm ET
Industry Sponsored Session | Advances in Targeted Therapy for CLL and AML: Efficacy and Practical Management of BCL-2 Inhibitors Presented by AbbVie (non-CE)
1:45 pm - 2:45 pm ET
General Session 5 | Chronic Disease and Complex Care Navigation Management
3:00 pm - 4:00 pm ET
Breakout Session 1 | Fertility
3:00 pm - 4:00 pm ET
Breakout Session 2 | Cold Caps/Cryotherapy
3:00 pm - 4:00 pm ET
Breakout Session 3 | How to Prepare for AONN+ FFL ONN/OPN Certification Exams
3:00 pm - 4:00 pm ET
Breakout Session 4 | Hematologic Malignancies
4:15 pm - 5:15 pm ET
Industry Sponsored Session | Survivorship Care Planning Presented by Bristol Myers Squibb (non-CE)
4:15 pm - 5:15 pm ET
Industry Sponsored Session | Industry Sponsored Session |Explore Data for an FDA-Approved Treatment Option in HR+, HER2– Breast Cancer in Certain Adjuvant or Metastatic Settings Presented by Lilly PP-AL-US-2989 © LillyUSA, LLC 2021. All rights reserved. (non-CE)
5:00 pm - 6:00 pm ET
Exhibit Hall Open (non-CE)
6:00 pm - 7:00 pm ET
Industry Sponsored Session | Presented by Merck (non-CE)

Saturday, November 20

8:00 am - 9:00 am ET
Industry Sponsored Session | ER-Targeted Cerianna PET: Identifying Patients That Can Benefit from Cerianna Presented by GE Healthcare (non-CE)
9:15 am - 10:15 am ET
General Session 6 | CAUTION: Metrics Can Be Addicting
10:30 am - 11:30 am ET
Industry Sponsored Session | Presented by Medtronic (non-CE)
10:30 am - 11:30 am ET
Industry Sponsored Session | | Cosela™: A Novel Myeloprotection Therapy Presented by G1 Therapeutics (non-CE)
11:00 am - 12:00 pm ET
Exhibit Hall Open (non-CE)
12:15 pm - 1:15 pm ET
Industry Sponsored Session | Presented by Genentech (non-CE)
1:30 pm - 2:30 pm ET
General Session 7 | Acuity
2:45 pm - 3:45 pm ET
Breakout Session 1 | Fertility
2:45 pm - 3:45 pm ET
Breakout Session 2 | Cold Caps/Cryotherapy
2:45 pm - 3:45 pm ET
Breakout Session 3 | How to Prepare for AONN+ FFL ONN/OPN Certification Exams
2:45 pm - 3:45 pm ET
Breakout Session 4 | Hematologic Malignancies
4:00 pm - 5:00 pm ET
Industry Sponsored Session | Clinical Cases in Polycythemia Vera: When to Intervene with Jakafi® (ruxolitinib) | Focus on Adults with Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea Presented by Incyte (non-CE)
4:00 pm - 5:00 pm ET
Industry Sponsored Session | A Treatment Option for Patients with Myelodysplastic Syndromes Presented by Bristol Myers Squibb (non-CE)
4:30 pm - 5:30 pm ET
Exhibit Hall Open (non-CE)
5:30 pm - 6:30 pm ET
Industry Sponsored Session | Presented by Janssen (non-CE)
6:30 pm - 7:30 pm ET
Attendee Networking (non-CE)

Sunday, November 21

9:15 am - 10:15 am ET
General Session 8 | Professional Oncology Navigation Taskforce Standards
10:30 am - 11:30 am ET
General Session 9 | Technology Innovation Integration to Address Underserved Disparate Patient Populations
11:30 am - 12:30 pm ET
AONN+ Leadership Live (non-CE)
12:45 pm - 1:45 pm ET
General Session 10 | Understanding the CoC
2:00 pm ET
Closing Remarks

*Subject to change.

Register Today!

Thank You to Our Corporate Sponsors and Alliance Partners!

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner